| Gene symbol | TP53 | Synonyms | BCC7, BMFS5, LFS1, P53, TRP53 | Type of gene | protein-coding |
| Chromosome | 17 | Map location | 17p13.1 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | tumor protein p53 | ||||
| GTO ID | GTC0229 |
| Trial ID | NCT02340117 |
| Disease | Pancreatic Cancer |
| Altered gene | P53 |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | Gene transfer |
| Treatment | SGT-53 |
| Phase | Phase2 |
| Recruitment status | Recruiting |
| Title | Phase II Study of Combined Targeted p53 Gene Therapy (SGT-53) Plus Gemcitabine/Nab-Paclitaxel for Treatment of Metastatic Pancreatic Cancer |
| Year | 2014 |
| Country | United States |
| Company sponsor | SynerGene Therapeutics, Inc. |
| Other ID(s) | SGT53-02-1 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||||||||
|
|||||||||||||